Clinical Trial Update: Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

View source ↗

Summary

A clinical trial evaluated the safety of adalimumab in rheumatoid arthritis patients who have not previously received DMARDs or biologic therapy and who exhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-10-26